Get the Stockscreener App
1.14
2.56%
-0.03
After Hours:
1.15
0.01
+0.88%
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
Microstrategy Inc. – 8% PRF PERPETUAL USD 100 – Ser A’s (STRK) Stock: A Week-by-Week Analysis - The News Heater
Monday.Com Ltd (MNDY) Shares Down Despite Recent Market Volatility - The News Heater
Mira Pharmaceuticals Inc (MIRA) Stock: Evaluating the Market Performance - The News Heater
Vanda Pharmaceuticals Inc (VNDA) Shares Rise Despite Market Challenges - The News Heater
Air Transport Services Group Inc (ATSG) Stock: Evaluating the Market Performance - The News Heater
Report: OpenAI's ex-CTO, Mira Murati, has recruited OpenAI co-founder John Schulman - Yahoo Finance
OpenAI cofounder John Schulman is joining Mira Murati’s startup after brief stint at Anthropic - Yahoo Finance
Kernel and Mira Launch Industry’s First $300M Secured AI API - GlobeNewswire Inc.
Mira Network Launches $10M Grant Program for AI Builders - EIN News
UCalgary researchers to validate Mira Hormone Monitor - Yahoo Finance
TEVA Stock Drops Over 5% Amid Financial Struggles - GuruFocus.com
MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End - ACCESS Newswire
MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA - accessnewswire.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - MSN
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance - ACCESS Newswire
MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 - ACCESS Newswire
MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - ACCESS Newswire
Wealth Enhancement Advisory Services LLC Acquires 6,454 Shares of PPL Co. (NYSE:PPL) - Defense World
International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance
Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha
Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha
Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World
Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa
Mira Pharmaceuticals appoints new accounting firm - Investing.com
Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart
StatementProposed Amendments To The Air Passenger Protection Regulations - Barchart
Should You Buy Joby Aviation Stock While It's Below $10? - Barchart
C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart
Is Xcel Energy Stock Underperforming The Nasdaq? - Barchart
2 Fantastic Beaten-Down Growth Stocks Down 35% And 21% To Buy - Barchart
Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2On December 19, 2024, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) disclosed that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, - Defense World
Stocks In Play: Canacol Energy Ltd. - Barchart
Grain Spreads: Profit Taking Theme - Barchart
Stocks Rally On Dovish PCE Inflation Report - Barchart
The Current State Of HR Is Unacceptable - Barchart
Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart
Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart
Is W.R. Berkley Stock Outperforming The Dow? - Barchart
PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart
US proposes voluntary guidelines for self-driving vehicles in waning days of Biden administration - Barchart
Takeaways From The Associated Press’ Reporting On Prison Labor In Alabama - Barchart
Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart
Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart
Is PPG Industries Stock Underperforming The S&P 500? - Barchart
Stocks Regain Footing On Dovish PCE Inflation Report - Barchart
Enterprise Products Stock Rises 25% YTD: Should You Buy Now Or Avoid It? - Barchart
Three Reasons Why PESI Is Risky And One Stock To Buy Instead - Barchart
SCARBOROUGH INNOVATES PARTNERS WITH SUNRAY VENTURE CAPITAL TO ACCELERATE LOCAL STARTUPS WITH 'CATALYST IGNITE' - Barchart
Knightscope K7 Alpha Testing Underway And 2024 Recap - Barchart
Take-Two (NASDAQ:TTWO): Strongest Q3 Results From The Video Gaming Group - Barchart
Stocks Pare Losses on Dovish PCE Report, But Threats Remain from Triple-Witching and Government Shutdown - Barchart
Q3 Video Conferencing Earnings: Five9 (NASDAQ:FIVN) Earns Top Marks - Barchart
3 Reasons To Sell BALY And 1 Stock To Buy Instead - Barchart
Rude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart
Crude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart
2025 Picks: 2 Stocks To Buy Now For 50% Upside - Barchart
Three Reasons Why GPRO Is Risky And One Stock To Buy Instead - Barchart
Beyond Reality: Investing In AR/VR Tech For Future Gains - Barchart
Federal Reserve's Preferred Inflation Gauge Shows Price Pressures Eased Last Month - Barchart
Senores Pharmaceuticals IPO: Pharma Firms ₹500 Crore Public Issue To Open On December 20 - Free Press Journal
Media advisoryThe Governments of Canada and Quebec will make an announcement to strengthen supply chains in Québec - Barchart
The number of Americans applying for unemployment benefits falls significantly after last week's big jump - Barchart
0.69%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):